Literature DB >> 17291369

Oligodendrocyte pathophysiology: a new view of schizophrenia.

Devorah Segal1, Jessica R Koschnick, Linda H A Slegers, Patrick R Hof.   

Abstract

A recent focus of schizophrenia research is disruption of white-matter integrity as a key facet of this complex disorder. This was spurred, partly, by new imaging modalities, magnetic transfer imaging and diffusion tensor imaging, which showed differences in white-matter integrity and tract coherence in persons with schizophrenia compared to controls. Oligodendrocytes, in particular, have been the subject of increased study after gene microarray analyses revealed that six myelin-related genes specific to oligodendrocytes have decreased expression levels in schizophrenia. Oligodendrocytes have also been shown to be decreased in number in the superior frontal gyrus of subjects with schizophrenia. The MAG knockout mouse, missing a myelin-related gene linked to schizophrenia, may prove to be a useful animal model for the dysmyelination observed in the human disease. Studies currently ongoing on this model have found changes in dendritic branching patterns of pyramidal cells in layer III of the prefrontal cortex. Further characterization of the pathology in these mice is underway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291369     DOI: 10.1017/S146114570600722X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  32 in total

1.  Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.

Authors:  Aristotle N Voineskos; Daniel Felsky; Natasa Kovacevic; Arun K Tiwari; Clement Zai; M Mallar Chakravarty; Nancy J Lobaugh; Martha E Shenton; Tarek K Rajji; Dielle Miranda; Bruce G Pollock; Benoit H Mulsant; Anthony R McIntosh; James L Kennedy
Journal:  Cereb Cortex       Date:  2012-07-06       Impact factor: 5.357

2.  Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia.

Authors:  Toshiyuki Ohtani; Sylvain Bouix; Amanda E Lyall; Taiga Hosokawa; Yukiko Saito; Eric Melonakos; Carl-Fredrik Westin; Larry J Seidman; Jill Goldstein; Raquelle Mesholam-Gately; Tracey Petryshen; Joanne Wojcik; Marek Kubicki
Journal:  Cortex       Date:  2015-06-06       Impact factor: 4.027

3.  Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth.

Authors:  Stéphane Budel; Thihan Padukkavidana; Betty P Liu; Zeny Feng; Fenghua Hu; Sam Johnson; Juha Lauren; James H Park; Aaron W McGee; Ji Liao; Althea Stillman; Ji-Eun Kim; Bao-Zhu Yang; Stefano Sodi; Joel Gelernter; Hongyu Zhao; Fuki Hisama; Amy F T Arnsten; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

4.  Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorder.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Dorota Maciag; Monica Sathyanesan; Abiye H Iyo; Mohadetheh Moulana; Patrick B Kyle; William L Woolverton; Jose Javier Miguel-Hidalgo; Craig A Stockmeier; Samuel S Newton
Journal:  J Psychiatr Res       Date:  2015-04-20       Impact factor: 4.791

Review 5.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

6.  Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia.

Authors:  Ali Torkamani; Brian Dean; Nicholas J Schork; Elizabeth A Thomas
Journal:  Genome Res       Date:  2010-03-02       Impact factor: 9.043

7.  White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis.

Authors:  Matthew D Perlstein; Moeed R Chohan; Ioana L Coman; Kevin M Antshel; Wanda P Fremont; Matthew H Gnirke; Zora Kikinis; Frank A Middleton; Petya D Radoeva; Martha E Shenton; Wendy R Kates
Journal:  Schizophr Res       Date:  2013-12-08       Impact factor: 4.939

Review 8.  Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Authors:  Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

9.  Abnormalities in white matter connections between orbitofrontal cortex and anterior cingulate cortex and their associations with negative symptoms in schizophrenia: a DTI study.

Authors:  Toshiyuki Ohtani; Sylvain Bouix; Taiga Hosokawa; Yukiko Saito; Ryan Eckbo; Thomas Ballinger; Andrew Rausch; Eric Melonakos; Marek Kubicki
Journal:  Schizophr Res       Date:  2014-06-21       Impact factor: 4.939

10.  A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.

Authors:  Helen M Knight; Benjamin S Pickard; Alan Maclean; Mary P Malloy; Dinesh C Soares; Allan F McRae; Alison Condie; Angela White; William Hawkins; Kevin McGhee; Margaret van Beck; Donald J MacIntyre; John M Starr; Ian J Deary; Peter M Visscher; David J Porteous; Ronald E Cannon; David St Clair; Walter J Muir; Douglas H R Blackwood
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.